FDAnews Drug Daily Bulletin

AFFERENZ ENTERS 2006 WITH VISION FOR THE FUTURE OF CLINICAL TRIALS

March 28, 2006
A A

Afferenz, a leading eClinical software and services company that addresses the information technology needs within the clinical trials environment, continues to change the way organizations execute their clinical development initiatives. Following a strong year of global growth, and experience in running ASP trials that dates back to 1999, 2006 marks Afferenz's transition from a hidden industry gem to one with a substantial market position. With a vision for end-to-end solutions for clinical development for today and beyond, Afferenz is determined to create the new standard for clinical data and trial management, and efficiencies in drug, biotechnology, and medical device development.
Business Wire